Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination.

De Herdt D, Lefevere E, Brouwers V, Hartvig L, Geeraerts E, Hsiao C-C, Chen AJQ, Pinto R, Duvey G, Burbidge S, et al.